𝗖𝘆𝗽𝗿𝗼𝘁𝗲𝘅 𝗮𝗻𝗱 Evotec 𝘄𝗶𝗹𝗹 𝗮𝘁𝘁𝗲𝗻𝗱 𝘁𝗵𝗲 𝗗𝗠𝗗𝗚 𝟱𝟭𝘀𝘁 𝗔𝗻𝗻𝗶𝘃𝗲𝗿𝘀𝗮𝗿𝘆 𝗢𝗽𝗲𝗻 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝘁𝗵𝗶𝘀 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿. Dermot McGinnity, EVP Head of Global Discovery DMPK, will be amongst the speakers in the 2025 DMDG Debate session, which will address the following motion: "This house believes that social media has more potential to positively impact drug discovery and development than peer reviewed articles". • 𝗖𝗮𝗺𝗯𝗿𝗶𝗱𝗴𝗲, 𝗨𝗞 • 𝗦𝗲𝘀𝘀𝗶𝗼𝗻 𝟵: 𝗧𝗵𝗲 𝗗𝗠𝗗𝗚 𝗗𝗲𝗯𝗮𝘁𝗲 • 𝗪𝗲𝗱𝗻𝗲𝘀𝗱𝗮𝘆 𝟯𝗿𝗱 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿, 𝟭𝟳:𝟯𝟬 𝗕𝗦𝗧 Arrange meetings with our colleagues, Steve Madden, SVP, Head, Global Operations Cyprotex and Rachel Upcott Gill, Principal Scientist, Drug Metabolism: https://hubs.ly/Q03zfCF00
